Search - tctmd.com

Displaying 1 - 20 of 35

Sort: Relevancy | Date

News Features

TCTMD Looks Back on 5 Years of Its Kahn Journalism Fellowship

L.A. McKeown

December 26, 2019

News Features

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Shelley Wood

December 23, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2019

Shelley Wood

November 29, 2019

News Conference News VEITH 2019

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

L.A. McKeown

November 26, 2019

News Conference News AHA 2019

Inclisiran Slashes LDL in ASCVD Patients: ORION-10

Yael L. Maxwell

November 16, 2019

News Daily News

CMS Confirms Substantial Cuts to Cardiac CT Reimbursement in 2020

Yael L. Maxwell

November 08, 2019

News Conference News TCT 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Caitlin E. Cox

October 10, 2019

Presentation TCT 2019

Emerging Safety Signals and FDA’s Medical Device Safety Action Plan: Responses to the Late Mortality Signal

Presenter: Rebecca Ward

September 26, 2019

Presentation TCT 2019

Potential Study Designs to Address the Mortality Safety Signal

Presenter: Laura Mauri

September 26, 2019

Presentation TCT 2019

Informed Consent and Impact on Clinical Practice: A Clinician’s Perspective and a Pathway Forward

Presenter: Sahil Parikh

September 26, 2019

Presentation TCT 2019

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Presenter: Ian Meredith AM

September 26, 2019

Presentation TCT 2019

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

Presenter: Elazer Edelman

September 26, 2019

Presentation TCT 2019

Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data

Presenter: Krishna Rocha-Singh

September 26, 2019

Presentation TCT 2019

New Insights From Our Meta-Analysis of Paclitaxel-Coated Device Randomized Trials for SFA Disease (And the Response It Has Generated)

Presenter: Konstantinos Katsanos

September 26, 2019

Presentation TCT 2019

Industry’s Perspectives on the US and Non-US EFS Landscape

Presenter: Neil Moat

September 26, 2019

Presentation TCT 2019

From EFS to Pivotal Trial: Bridging the Gap and Lessons Learned

Presenter: Pieter Kappetein

September 26, 2019

Presentation TCT 2019

Promoting Innovation Through EFS: MDIC Perspectives

Presenter: Chip Hance

September 26, 2019

Presentation TCT 2019

The US EFS and Breakthrough Devices Programs: An FDA Update

Presenter: Andrew Farb

September 26, 2019

Presentation TCT 2019

Keynote Lecture: A Vision for an Evolving Regulatory and Healthcare System

Presenter: Robert Califf

September 26, 2019

Presentation TCT 2019

Keynote Lecture: New Technology Assessment and Reimbursement Synergy — Forward Strides

Presenter: Lori Ashby

September 26, 2019

Advertisement

TCTMD Looks Back on 5 Years of Its Kahn Journalism Fellowship

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

TCTMD’s Top 10 Most Popular Stories for November 2019

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

Inclisiran Slashes LDL in ASCVD Patients: ORION-10

CMS Confirms Substantial Cuts to Cardiac CT Reimbursement in 2020

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Emerging Safety Signals and FDA’s Medical Device Safety Action Plan: Responses to the Late Mortality Signal

Potential Study Designs to Address the Mortality Safety Signal

Informed Consent and Impact on Clinical Practice: A Clinician’s Perspective and a Pathway Forward

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data

New Insights From Our Meta-Analysis of Paclitaxel-Coated Device Randomized Trials for SFA Disease (And the Response It Has Generated)

Industry’s Perspectives on the US and Non-US EFS Landscape

From EFS to Pivotal Trial: Bridging the Gap and Lessons Learned

Promoting Innovation Through EFS: MDIC Perspectives

The US EFS and Breakthrough Devices Programs: An FDA Update

Keynote Lecture: A Vision for an Evolving Regulatory and Healthcare System

Keynote Lecture: New Technology Assessment and Reimbursement Synergy — Forward Strides

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content